Naturalistic outcome of medication-naïve obsessive compulsive disorder treated with serotonin reuptake inhibitors.
Medication-naïve
Obsessive compulsive disorder
Serotonin uptake inhibitors
Treatment outcome
Journal
Asian journal of psychiatry
ISSN: 1876-2026
Titre abrégé: Asian J Psychiatr
Pays: Netherlands
ID NLM: 101517820
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
11
09
2020
revised:
08
03
2021
accepted:
05
04
2021
pubmed:
1
5
2021
medline:
22
6
2021
entrez:
30
4
2021
Statut:
ppublish
Résumé
The data on the course of obsessive compulsive disorder (OCD) is mostly derived from studying chronic, severely ill patients with varying degree of treatment resistance. We studied the course and outcome of OCD patients who were medication-naïve at initial assessment compared to those who were medicated. We analyzed the clinical chart data of all patients with a primary diagnosis of OCD attending a speciality OCD clinic in India during a specified period and compared outcome between medication-naïve (n = 75) and medicated (n = 117) patients. The mean time to remission was shorter in the medication-naïve [18.99 months (95 % CI: 14.61-23.37)] compared to medicated [33.91 months (95 % CI: 27.55-40.28)] patients. The survival distribution of the two groups was significantly different as per the log-rank test (χ2 = 5.76, p = 0.02). In the Cox proportional hazards regression, medication-naïve status predicted time to remission. Overall, the rate of remission was the same in both groups (57 %). Medication-naïve OCD patients seem to remit faster than the previously treated patients. Future prospective naturalistic studies can compare the outcome of medication naïve OCD patients treated with medications and CBT.
Identifiants
pubmed: 33930709
pii: S1876-2018(21)00098-8
doi: 10.1016/j.ajp.2021.102642
pii:
doi:
Substances chimiques
Serotonin Uptake Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102642Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021. Published by Elsevier B.V.